Amrize Ltd (AMRZ)
Official siteBASIC MATERIALS • BUILDING MATERIALS • NYSE
Market Cap: $21.77B
Last updated: Nov 17, 2026 at 11:04 AM ET
Amrize Ltd (AMRZ) Stock Forecast
Analysts expect Amrize (AMRZ) to earn $2.29 per share in the fiscal year ending Dec 31, 2026, on revenue of $12.33B. Of 20 analysts, 9 rate the stock Buy or Strong Buy, 9 Hold and 2 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 10 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 20 ratings average 2.65, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 45% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 10.0% |
| Buy | 7 | 35.0% |
| Hold | 9 | 45.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 2 | 10.0% |
- Consensus
- Hold
- Total analysts
- 20
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 10.9% and revenue estimates rise 4.1%.
- Fiscal year ending Dec 31, 2026
- $2.29
- EPS consensus, revenue $12.33B
- Fiscal year ending Dec 31, 2027
- $2.54
- EPS consensus, revenue $12.84B
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.29 | $2.16 to $2.41 | 12 | $12.33B | $12.25B to $12.41B | 20 |
| Dec 31, 2027 | $2.54 | $2.15 to $2.91 | 16 | $12.84B | $11.77B to $13.65B | 23 |
Quarterly Estimates
The EPS consensus falls from $0.64 for the quarter ending Dec 31, 2026 to -$0.23 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.64 | $0.57 to $0.74 | 12 | $3.01B | $2.83B to $3.19B | 12 |
| Mar 31, 2027 | -$0.23 | -$0.27 to -$0.18 | 6 | $2.21B | $2.02B to $2.28B | 7 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 22 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 10 |
| Fiscal year ending Dec 31, 2027 | 1 | 9 |
| Quarter ending Mar 31, 2027 | 0 | 3 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 10.9% from $2.57.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $2.29 | $2.28 | $2.43 | $2.49 | $2.57 | -11.0% |
| Fiscal year ending Dec 31, 2027 | $2.54 | $2.58 | $2.71 | $2.86 | $3.05 | -16.6% |
| Quarter ending Mar 31, 2027 | -$0.23 | -$0.17 | -$0.17 | -$0.16 | -$0.12 | N/A |
Frequently Asked Questions About AMRZ
What is the AMRZ stock forecast?
Consensus analyst estimates put Amrize's EPS at $2.29 for the fiscal year ending Dec 31, 2026, on revenue of $12.33B. The consensus rating from 20 analysts is Hold.
How do analysts rate AMRZ stock?
Of 20 analysts covering Amrize, 2 rate it Strong Buy, 7 Buy, 9 Hold, 0 Sell and 2 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from AMRZ next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.29, with estimates from $2.16 to $2.41 from 12 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.54, with estimates from $2.15 to $2.91 from 16 analysts.
What revenue do analysts expect from Amrize next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $12.33B, with estimates from $12.25B to $12.41B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $12.84B, with estimates from $11.77B to $13.65B.
How many analysts cover AMRZ?
20 analysts rate Amrize stock, and 12 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
AMRZ pages: Overview, Forecast, Financials, Valuation, Competitors, Government Contracts